مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: Gastrointestinal permeability in ovarian cancer and breast cancer patients treated with paclitaxel and platinum.
Normal view MARC view ISBD view

Gastrointestinal permeability in ovarian cancer and breast cancer patients treated with paclitaxel and platinum. [electronic resource]

By:
  • Melichar, Bohuslav
Contributor(s):
  • Hyspler, Radomír
  • Dragounová, Emanuela
  • Dvorák, Josef
  • Kalábová, Hana
  • Tichá, Alena
Producer: 20070925Description: 155 p. digitalISSN:
  • 1471-2407
Subject(s):
  • Adenocarcinoma -- drug therapy
  • Adult
  • Aged
  • Antibodies, Monoclonal -- administration & dosage
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
  • Breast Neoplasms -- drug therapy
  • Carboplatin -- administration & dosage
  • Cell Membrane Permeability -- drug effects
  • Cisplatin -- administration & dosage
  • Female
  • Gastrointestinal Tract -- metabolism
  • Humans
  • Intestinal Absorption -- drug effects
  • Lactulose -- metabolism
  • Mannitol -- metabolism
  • Middle Aged
  • Neoplasms, Glandular and Epithelial -- drug therapy
  • Ovarian Neoplasms -- drug therapy
  • Paclitaxel -- administration & dosage
  • Sucrose -- metabolism
  • Trastuzumab
  • Xylose -- metabolism
Online resources:
  • Available from publisher's website
In: BMC cancer vol. 7
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

Log in to your account to post a comment.
Browse results Close
Previous
Back to results
Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 1 Hyperlipidaemia and cardiovascular disease: HDL, inflammation and surprising results of AIM-HIGH study.
    by Nofer, Jerzy-Roch
  • 2 High-density lipoprotein, sphingosine 1-phosphate, and atherosclerosis.
    by Nofer, Jerzy-Roch
  • 3 Signal transduction by HDL: agonists, receptors, and signaling cascades.
    by Nofer, Jerzy-Roch
  • 4 Estrogens and atherosclerosis: insights from animal models and cell systems.
    by Nofer, Jerzy-Roch
  • 5 Hyperlipidaemia and cardiovascular disease: the quantity does not turn into quality!
    by Nofer, Jerzy-Roch
  • 6 Hyperlipidemia and cardiovascular disease: triglycerides - a revival of cardiovascular risk factor?
    by Nofer, Jerzy-Roch
  • 7 Hyperlipidemia and cardiovascular disease: should we abandon HDL cholesterol as a therapeutic target in coronary heart disease.
    by Nofer, Jerzy-Roch
  • 8 Atheroprotective effects of high-density lipoproteins.
    by Assmann, Gerd
  • 9 Atheroprotective effects of high-density lipoprotein-associated lysosphingolipids.
    by Nofer, Jerzy-Roch
  • 10 Frail HDLs and stiff arteries in type 2 diabetes in juveniles.
    by von Eckardstein, Arnold
  • 11 HDL scavenger receptor class B type I and platelet function.
    by Nofer, Jerzy-Roch
  • 12 Author's reply.
    by Stypmann, Jörg
  • 13 Current understanding of the role of high-density lipoproteins in atherosclerosis and senescence.
    by Nofer, Jerzy-Roch
  • 14 Cardiovascular risk assessment in metabolic syndrome: view from PROCAM.
    by Assmann, Gerd
  • 15 Atheroprotective role of high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P).
    by Potì, Francesco
  • 16 Low density receptor-related protein 1 (LRP1) promotes anti-inflammatory phenotype in murine macrophages.
    by May, Petra
  • 17 High-density lipoproteins, platelets and the pathogenesis of atherosclerosis.
    by Nofer, Jerzy-Roch
  • 18 Establishing reference intervals for sex hormones on the analytical platforms Advia Centaur and Immulite 2000XP.
    by Schüring, Andreas N
  • 19 Hypothalamic dopaminergic stimulation in cluster headache.
    by Lepper, Anne
  • 20 Low density lipoproteins inhibit the Na+/H+ antiport in human platelets via activation of p38MAP kinase.
    by Nofer, Jerzy-Roch
Close

Gastrointestinal permeability in ovarian cancer and breast cancer patients treated with paclitaxel and platinum.

APA

Melichar B., Hyspler R., Dragounová E., Dvorák J., Kalábová H. & Tichá A. (20070925). Gastrointestinal permeability in ovarian cancer and breast cancer patients treated with paclitaxel and platinum. : BMC cancer.

Chicago

Melichar Bohuslav, Hyspler Radomír, Dragounová Emanuela, Dvorák Josef, Kalábová Hana and Tichá Alena. 20070925. Gastrointestinal permeability in ovarian cancer and breast cancer patients treated with paclitaxel and platinum. : BMC cancer.

Harvard

Melichar B., Hyspler R., Dragounová E., Dvorák J., Kalábová H. and Tichá A. (20070925). Gastrointestinal permeability in ovarian cancer and breast cancer patients treated with paclitaxel and platinum. : BMC cancer.

MLA

Melichar Bohuslav, Hyspler Radomír, Dragounová Emanuela, Dvorák Josef, Kalábová Hana and Tichá Alena. Gastrointestinal permeability in ovarian cancer and breast cancer patients treated with paclitaxel and platinum. : BMC cancer. 20070925.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site